AMEX · Biotechnology

ATNM (ATNM) Stock

$0.80 +1.32% AMEX: ATNM Healthcare

Valuation

MetricValue
Price$0.80
Market Cap$25.02M
P/E Ratio-1.07
P/B Ratio4.59
P/S Ratio411.36
EPS (TTM)$0.00
52-Week High$1.89
52-Week Low$0.80
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-425.00%
ROA-65.38%
ROCE-450.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin-260.79%
Debt/Equity0.66
Current Ratio6.13

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$1.0M$0$0$0
Operating Profit$-25.0M$-34.0M$-52.0M$-42.0M$-36.0M
Net Profit$-25.0M$-33.0M$-49.0M$-38.0M$-34.0M
EPS$-1.20$-1.37$-1.83$-1.27$-1.09
Op Margin-2182.2%-3311.1%-64098.8%—-40274.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$80.0M$114.0M$81.0M$77.0M$52.0M
Total Liabilities$7.0M$48.0M$45.0M$44.0M$44.0M
Cash$78.0M$109.0M$77.0M$73.0M$48.0M
Borrowings$0$3.0M$2.0M$2.0M$2.0M

Latest News

US to Impose 25% Section 301 Tariff on Certain Brazilian Imports MT Newswires · Jul 17, 2026 Fed's Jefferson Open to Rate Hike If Inflation Persists MT Newswires · Jul 17, 2026 Benchmark (BHE): Buy, Sell, or Hold Post Q1 Earnings? StockStory · Jul 17, 2026 Rapidus and Cadence Partner on Agentic AI for Advanced SoC Design Business Wire · Jul 17, 2026 Hazardous Canadian wildfire smoke choking millions in US AFP · Jul 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-21.0M$9.0M$-47.0M$-33.0M$-25.0M
Investing Cash Flow$0$-1.0M$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$14.0M$31.0M$-33.0M$-4.0M$-25.0M
Free Cash Flow$-21.0M$8.0M$-47.0M$-33.0M$-25.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-62.08%
Quick Ratio5.89
Interest Coverage—
Return 1Y-38.58%
Return 3Y-86.91%
Return 5Y-87.25%

Ownership

Insiders Held2.35%
Institutions Held20.61%
Institutions Float Held21.10%
Institutional HolderSharesReport Date
Vanguard Capital Management LLC1,255,5162026-03-31
Acadian Asset Management. LLC600,8192026-03-31
Millennium Management Llc564,6002026-03-31
Renaissance Technologies, LLC471,6002026-03-31
Blackrock Inc.371,2102026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANVS $1.70 +0.59% -1.54 $33.45M 0.00%
FGENFibroGen, Inc. $9.07 -1.63% 0.22 $36.69M 0.00%
KZR $7.29 +0.00% -0.96 $53.86M 0.00%
LVTXLAVA Therapeutics N.V. $1.74 -3.87% -2.42 $45.77M 0.00%
OKUR $3.95 -2.47% -0.72 $54.01M 0.00%

About ATNM

ATNM is led by CEO Sandesh C. Seth, employs 31 people, headquartered in US, publicly traded since 2012.

ATNM stock trades at $0.80 with a market capitalization of $25.02M. The stock is valued at a price-to-earnings (P/E) ratio of -1.07, price-to-book of 4.59, price-to-sales of 411.36. Over the past 52 weeks the stock has ranged between $0.80 and $1.89, and currently trades 57.7% below its 52-week high.

On profitability, ATNM generates a return on equity (ROE) of -425.00%, return on capital employed of -450.00%, an operating margin of 0.00%, a net profit margin of -260.79%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides